10 Year Financial Data of Select Medical Holdings Corporation (SEM)

8.02 (1y: -12%)

Market Cap	1.12 B	P/E(ttm)	8.10
Enterprise Value	2.62 B	P/B	1.60

SEM- NYSE (USA)
Select Medical Holdings Corporation

Not Rated

Top Ranked Predictable Companies

$8.02

2 Severe Warning Signs 5 Good Signs

Bookmark

Annual Rates (per share)	5 yrs*	12 months*
Revenue Growth (%)	10.6	8.1
EBITDA Growth (%)	12.5	5.4
Free Cash Flow Growth (%)	43.6	17.1
Book Value Growth (%)	0	-8.9

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals									Quarterly
Fiscal Period	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue per Share ($)	--	--	--	10.85	26.03	14.99	18.61	21.21	20.91	5.25	4.91	5.18	5.37	5.45
EBITDA per Share	--	--	--	1.35	3.57	1.91	2.54	2.88	2.75	0.76	0.71	0.63	0.70	0.71
Free Cashflow per Share	--	--	--	0.26	1.25	0.58	1.14	1.66	1.44	-0.03	0.62	0.42	0.59	-0.19
Earnings per Share ($)	--	--	--	-0.01	0.61	0.48	0.71	1.05	1.01	0.29	0.31	0.17	0.29	0.24
Book Value per Share	--	--	--	-0.88	8.59	4.92	5.46	5.16	5.40	5.93	5.65	6.45	5.20	5.40
Month End Stock Price	--	--	--	--	10.62	7.31	8.48	9.43	9.00	7.69	10.11	11.23	9.43	9.00
Ratios	Annuals									Quarterly
Fiscal Period	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Return on Equity %	--	--	--	--	10.20	9.90	13.10	20.70	18.40	19.60	20.00	10.80	22.00	18.40
Return on Assets %	-1.30	4.30	1.40	0.90	2.90	2.90	3.90	5.40	4.80	6.00	6.40	3.60	5.60	4.80
Return on Capital - Joel Greenblatt %	36.30	74.50	36.90	35.40	42.30	37.70	49.70	60.60	52.80	55.20	61.20	48.00	58.40	52.80
Debt to Equity	-6.84	-9.32	-10.71	-10.34	1.90	1.85	1.72	2.08	2.02	1.71	1.59	1.52	2.08	2.02

Gross Margin %	19.90	19.80	16.70	16.80	18.80	17.10	17.70	17.10	16.70	17.80	18.30	16.10	16.30	16.70
Operating Margin %	6.40	13.90	9.70	9.10	10.50	9.90	11.10	11.40	11.00	12.30	12.50	9.90	10.90	11.00
Net Margin %	-1.50	5.10	1.80	1.00	3.40	3.20	3.80	5.00	4.60	5.60	5.80	3.40	5.30	4.60

Days Sales Outstanding	50.40	39.40	49.70	53.00	50.00	54.00	53.80	44.50	52.00	57.00	51.40	50.10	44.20	52.00

Debt to Revenue	0.90	0.85	0.89	0.84	0.63	0.61	0.50	0.51	2.01	1.93	1.83	1.90	2.01	2.01
COGS to Revenue	0.80	0.80	0.83	0.83	0.81	0.83	0.82	0.83	0.83	0.82	0.82	0.84	0.84	0.83
Interest Exp. to Revenue %	-5.68	-7.05	-6.93	-6.75	-5.91	-4.70	-3.53	-3.22	-3.13	-3.22	-3.17	-3.44	-3.06	-3.13

Asset Turnover	0.86	0.85	0.80	0.84	0.86	0.88	1.01	1.07	0.27	0.27	0.27	0.26	0.27	0.27
Buyback Ratio	3.70	--	-0.80	-0.30	-0.20	-0.30	-0.20	-1.20	--	-0.20	-1.00	-2.20	-1.70	--
Income Statement	Annuals (USD $) View: $ %									Quarterly
Fiscal Period	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue	1,858	1,851	1,992	2,153	2,240	2,390	2,805	2,949	2,955	744	750	714	741	750
Cost of Goods Sold	1,489	1,485	1,660	1,792	1,820	1,982	2,309	2,444	2,457	612	613	599	620	625
Gross Profit	370	367	332	362	420	408	496	505	498	132	138	115	121	125

Selling, General, &Admin. Expense	207	62.32	80.44	93.33	113	62.12	62.35	66.19	69.37	14.22	18.55	17.13	16.29	17.40
Earnings Before DDA	165	306	253	268	307	305	382	400	391	108	109	86.36	97.07	98.33

Depreciation, Depletion and Amortization	46.12	48.02	58.62	71.79	70.98	68.71	71.52	63.31	62.91	16.20	15.43	15.54	16.15	15.80

Operating Income	119	258	194	196	236	236	311	337	328	91.60	93.51	70.82	80.92	82.53
Interest Income/Expense	-106	-131	-138	-145	-132	-112	-98.89	-94.95	-94.49	-23.92	-23.80	-24.58	-22.66	-23.46
Net Income	-27.92	94.88	35.43	22.44	75.28	77.64	108	148	141	41.54	43.17	24.11	39.41	34.42

Preferred dividends	23.52	22.66	23.81	24.97	19.54	--	--	--	--	--	--	--	--	--
Earnings per Share ($)	--	--	--	-0.01	0.61	0.48	0.71	1.05	1.01	0.29	0.31	0.17	0.29	0.24
Total Shares Outstanding	--	--	--	199	86.05	159	151	139	138	142	153	138	138	138
Balance Sheet	Annuals (USD $) View: $ %									Quarterly
Fiscal Period	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Cash and cash equivalents	49.74	81.60	4.53	64.26	83.68	4.37	12.04	40.14	4.50	9.27	21.52	49.68	40.14	4.50
Accounts Receivable	257	200	271	312	307	353	414	360	429	466	424	393	360	429
Other Current Assets	89.32	63.71	79.66	90.18	83.95	71.53	57.62	53.59	57.09	54.07	50.98	51.01	53.59	57.09
Total Current Assets	396	345	356	467	475	429	483	454	490	529	496	493	454	490

Property, Plant and Equipment	249	356	487	471	466	532	510	502	500	492	493	495	502	500
Intangible Assets	1,392	1,403	1,579	1,581	1,614	1,711	1,704	1,712	1,712	1,703	1,703	1,705	1,712	1,712
Other Long Term Assets	132	78.15	73.77	60.80	47.82	49.29	74.87	93.87	107	82.52	87.26	88.96	93.87	107
Total Assets	2,168	2,183	2,495	2,579	2,602	2,722	2,772	2,761	2,809	2,807	2,780	2,782	2,761	2,809

Accounts Payable	267	274	312	318	300	331	356	359	361	347	357	349	359	361
Current Portion of Long-Term Debt	51.61	43.40	28.87	30.18	4.15	168	27.46	29.48	30.08	33.55	32.13	24.68	29.48	30.08
Other Current Liabilities	--	--	0.00	0.00	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	318	317	341	348	304	500	384	388	391	381	389	374	388	391

Long-Term Debt	1,622	1,532	1,748	1,771	1,401	1,281	1,386	1,459	1,474	1,399	1,342	1,331	1,459	1,474
Other Long-Term Liabilities	472	502	572	634	158	157	179	197	200	187	185	188	197	200
Total Liabilities	2,413	2,352	2,661	2,754	1,863	1,938	1,949	2,044	2,066	1,967	1,916	1,892	2,044	2,066

Common Stock	0.21	0.21	0.21	0.21	0.16	0.16	0.15	0.14	0.14	0.14	0.14	0.14	0.14	0.14
Retained Earnings	48.81	121	131	128	169	248	329	243	274	360	394	418	243	274
Additional Paid-In Capital	-299	-295	-291	-289	579	536	494	474	469	480	469	471	474	469
Total Equity	-245	-169	-166	-174	739	784	823	717	743	840	864	890	717	743
Cashflow Statement	Annuals (USD $) View: $ %									Quarterly
Fiscal Period	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Net Income	-27.92	94.88	35.43	25.83	78.89	82.36	113	154	148	42.57	44.82	25.16	41.35	36.80
Depreciation, Depletion and Amortization	46.12	48.02	58.62	71.79	70.98	68.71	71.52	63.31	62.91	16.20	15.43	15.54	16.15	15.80
Cash Flow from Others	39.02	84.75	-8.04	9.82	15.77	-6.53	32.85	81.48	67.49	-50.59	50.38	34.58	47.11	-64.58
Cash Flow from Operations	57.21	228	86.01	107	166	145	217	299	279	8.18	111	75.27	105	-11.97

Investment for Property, Plant & Equipement	-110	-155	-166	-56.50	-57.88	-51.76	-46.02	-68.19	-70.43	-11.75	-16.18	-17.25	-23.00	-14.00
Cash Flow from Acquisitions	-112	71.71	-227	-4.96	-21.38	-166	-16.60	-20.73	-22.87	-7.84	-2.38	-1.23	-9.29	-9.98
Cash Flow from Investing	-221	-81.48	-383	-60.44	-77.92	-217	-54.74	-72.41	-93.30	-3.08	-18.56	-18.48	-32.28	-23.98

Net Issuance of Stock	-1,687	-0.04	0.25	-0.52	0.07	-43.90	-72.60	-45.09	-29.42	-25.64	-20.60	0.56	0.60	-9.98
Net Issuance of Debt	1,160	-98.66	221	15.21	-377	41.48	-58.95	67.59	64.26	18.87	-58.63	-23.64	131	15.54
Cash Flow for Dividends	-177	-1.76	-1.70	--	--	--	-4.61	-214	-214	-1.10	-0.58	-1.32	-211	-1.05
Other Financing	655	0.00	0.00	-1.96	308	-4.43	-18.56	-6.53	-10.74	-0.00	-0.00	-4.24	-2.29	-4.21
Cash Flow from Financing	-48.51	-100	220	12.73	-68.30	-6.85	-155	-198	-190	-7.87	-79.82	-28.64	-81.86	0.31

Net Change in Cash	-212	45.74	-77.07	59.73	19.42	-79.32	7.68	28.10	-4.77	-2.77	12.25	28.16	-9.53	-35.64

Free Cash Flow	-52.74	72.56	-80.06	50.93	108	92.78	171	230	208	-3.57	94.44	58.02	81.61	-25.97
Valuation Ratios (Daily)	Annuals									Quarterly
Fiscal Period	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

PE Ratio(ttm)
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals									Quarterly
Fiscal Period	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

SEM Quarterly/Annuals Reports

SEM: 10-Q - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer): (10-Q) - 2012-11-01
SEM: 10-Q - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer): (10-Q) - 2012-08-07
SEM: 10-Q - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer): (10-Q) - 2012-05-03
SEM: 10-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer): (10-K) - 2012-03-02
SEM: 10-Q - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer): (10-Q) - 2011-11-03

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

SEM Quarterly/Annuals Reports